BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Wilde AH, Snijder EJ, Kikkert M, van Hemert MJ. Host Factors in Coronavirus Replication. Curr Top Microbiol Immunol. 2018;419:1-42. [PMID: 28643204 DOI: 10.1007/82_2017_25] [Cited by in Crossref: 106] [Cited by in F6Publishing: 144] [Article Influence: 35.3] [Reference Citation Analysis]
Number Citing Articles
1 Colaco S, Chhabria K, Singh D, Bhide A, Singh N, Singh A, Husein A, Mishra A, Sharma R, Ashary N, Modi D. Expression map of entry receptors and infectivity factors for pan-coronaviruses in preimplantation and implantation stage human embryos. J Assist Reprod Genet 2021;38:1709-20. [PMID: 33913101 DOI: 10.1007/s10815-021-02192-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Alsalman AJ, Al Mohaini M, Malik MZ, Imran M, Alomar FA, Al Awwad N. Elevated Vulnerability of Chronic Leukemia Patients to COVID-19 Infection: A Systems Biology Approach. Dr Sulaiman Al Habib Med J. [DOI: 10.1007/s44229-022-00005-y] [Reference Citation Analysis]
3 Barbuddhe SB, Rawool DB, Gaonkar PP, Vergis J, Dhama K, Malik SS. Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic. Hum Vaccin Immunother 2020;16:3023-33. [PMID: 33121328 DOI: 10.1080/21645515.2020.1810496] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Anand R, Biswal S, Bhatt R, Tiwary BN. Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2). PeerJ 2020;8:e9855. [PMID: 33062414 DOI: 10.7717/peerj.9855] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ellis P, Somogyvári F, Virok DP, Noseda M, McLean GR. Decoding Covid-19 with the SARS-CoV-2 Genome. Curr Genet Med Rep 2021;:1-12. [PMID: 33457109 DOI: 10.1007/s40142-020-00197-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
6 Mustafa N, Zahoor H, Majoo FM. İnsan-COVID-19'da Pandemik SARS Coronavirus-2 Enfeksiyonları. İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi 2020. [DOI: 10.38079/igusabder.695778] [Reference Citation Analysis]
7 Murphy BG, Perron M, Murakami E, Bauer K, Park Y, Eckstrand C, Liepnieks M, Pedersen NC. The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. Vet Microbiol 2018;219:226-33. [PMID: 29778200 DOI: 10.1016/j.vetmic.2018.04.026] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 17.3] [Reference Citation Analysis]
8 [DOI: 10.1101/2020.06.17.20134015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Saçar Demirci MD, Adan A. Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection. PeerJ 2020;8:e9369. [PMID: 32547891 DOI: 10.7717/peerj.9369] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 25.5] [Reference Citation Analysis]
10 Zhang J, Yuan S, Peng Q, Ding Z, Hao W, Peng G, Xiao S, Fang L. Porcine Epidemic Diarrhea Virus nsp7 Inhibits Interferon-Induced JAK-STAT Signaling through Sequestering the Interaction between KPNA1 and STAT1. J Virol 2022;:e0040022. [PMID: 35442061 DOI: 10.1128/jvi.00400-22] [Reference Citation Analysis]
11 Luzon-Hidalgo R, Risso VA, Delgado A, Andrés-León E, Ibarra-Molero B, Sanchez-Ruiz JM. Evidence for a role of phenotypic mutations in virus adaptation. iScience 2021;24:102257. [PMID: 33817569 DOI: 10.1016/j.isci.2021.102257] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Prasad N, Gopalakrishnan N, Sahay M, Gupta A, Agarwal SK; COVID-19 Working Group of Indian Society of Nephrology. Epidemiology, Genomic Structure, the Molecular Mechanism of Injury, Diagnosis and Clinical Manifestations of Coronavirus Infection: An Overview. Indian J Nephrol 2020;30:143-54. [PMID: 33013059 DOI: 10.4103/ijn.IJN_191_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Xu X, Zhang QY, Chu XY, Quan Y, Lv BM, Zhang HY. Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge. Viruses 2021;13:2117. [PMID: 34834924 DOI: 10.3390/v13112117] [Reference Citation Analysis]
14 Swelum AA, Shafi ME, Albaqami NM, El-Saadony MT, Elsify A, Abdo M, Taha AE, Abdel-Moneim AE, Al-Gabri NA, Almaiman AA, Saleh Al-Wajeeh A, Tufarelli V, Staffa VN, Abd El-Hack ME. COVID-19 in Human, Animal, and Environment: A Review. Front Vet Sci 2020;7:578. [PMID: 33102545 DOI: 10.3389/fvets.2020.00578] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
15 Li H, Yang L, Liu FF, Ma XN, He PL, Tang W, Tong XK, Zuo JP. Overview of therapeutic drug research for COVID-19 in China. Acta Pharmacol Sin 2020;41:1133-40. [PMID: 32555446 DOI: 10.1038/s41401-020-0438-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
16 Chen DZ, Fan SR, Yang BJ, Yao HC, Wang YT, Cai JY, Jing CX, Pan ZH, Luo M, Yuze YQ, Liu GJ, Hao XJ. Phenanthridine Derivative Host Heat Shock Cognate 70 Down-Regulators as Porcine Epidemic Diarrhea Virus Inhibitors. J Nat Prod 2021;84:1175-84. [PMID: 33760626 DOI: 10.1021/acs.jnatprod.0c01252] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Wang W, Zhou Z, Xiao X, Tian Z, Dong X, Wang C, Li L, Ren L, Lei X, Xiang Z, Wang J. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation. Cell Mol Immunol 2021;18:945-53. [PMID: 33637958 DOI: 10.1038/s41423-020-00619-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
18 Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past. Front Immunol 2020;11:1949. [PMID: 32849654 DOI: 10.3389/fimmu.2020.01949] [Cited by in Crossref: 90] [Cited by in F6Publishing: 72] [Article Influence: 45.0] [Reference Citation Analysis]
19 [DOI: 10.1101/2020.03.03.20030650] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 Tabassum T, Rahman A, Araf Y, Ullah MA, Hosen MJ. Management of asthma patients during the COVID-19 pandemic: pathophysiological considerations to address the challenges. Beni-Suef Univ J Basic Appl Sci 2022;11. [DOI: 10.1186/s43088-022-00204-4] [Reference Citation Analysis]
21 Mészáros B, Sámano-Sánchez H, Alvarado-Valverde J, Čalyševa J, Martínez-Pérez E, Alves R, Shields DC, Kumar M, Rippmann F, Chemes LB, Gibson TJ. Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications. Sci Signal 2021;14:eabd0334. [PMID: 33436497 DOI: 10.1126/scisignal.abd0334] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
22 Samanta P, Ghosh AR. Environmental perspectives of COVID-19 outbreaks: A review. World J Gastroenterol 2021; 27(35): 5822-5850 [PMID: 34629805 DOI: 10.3748/wjg.v27.i35.5822] [Reference Citation Analysis]
23 Bratosiewicz-Wąsik J, Wąsik TJ. Does Virus-Receptor Interplay Influence Human Coronaviruses Infection Outcome? Med Sci Monit 2020;26:e928572. [PMID: 33311429 DOI: 10.12659/MSM.928572] [Reference Citation Analysis]
24 Pashkov EA, Korchevaya ER, Faizuloev EB, Svitich OA, Pashkov EP, Nechaev DN, Zverev VV. Potential of application of the RNA interference phenomenon in the treatment of new coronavirus infection COVID-19. Vopr Virusol 2021;66:241-51. [PMID: 34545716 DOI: 10.36233/0507-4088-61] [Reference Citation Analysis]
25 Irmak DK, Darıcı H, Karaöz E. Stem Cell Based Therapy Option in COVID-19: Is It Really Promising? Aging Dis 2020;11:1174-91. [PMID: 33014531 DOI: 10.14336/AD.2020.0608] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
26 Kardani K, Bolhassani A, Kardani M, Agi E; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran, Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran. Correlation of SARS-CoV-2 Infection with Hepatitis and Liver Disorders. JoMMID 2021;9:122-32. [DOI: 10.52547/jommid.9.3.122] [Reference Citation Analysis]
27 Shi Y, Shuai L, Wen Z, Wang C, Yan Y, Jiao Z, Guo F, Fu ZF, Chen H, Bu Z, Peng G. The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract. Emerg Microbes Infect 2021;10:481-92. [PMID: 33691601 DOI: 10.1080/22221751.2021.1899770] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
28 Waqas M, Haider A, Rehman A, Qasim M, Umar A, Sufyan M, Akram HN, Mir A, Razzaq R, Rasool D, Tahir RA, Sehgal SA. Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening. Biomed Res Int 2021;2021:1596834. [PMID: 33728324 DOI: 10.1155/2021/1596834] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
29 Santana MVS, Silva-Jr FP. De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning. BMC Chem 2021;15:8. [PMID: 33531083 DOI: 10.1186/s13065-021-00737-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
30 Bonny V, Maillard A, Mousseaux C, Plaçais L, Richier Q. [COVID-19: Pathogenesis of a multi-faceted disease]. Rev Med Interne 2020;41:375-89. [PMID: 32507520 DOI: 10.1016/j.revmed.2020.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
31 Hosoki K, Chakraborty A, Sur S. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective. J Allergy Clin Immunol 2020;146:285-99. [PMID: 32624257 DOI: 10.1016/j.jaci.2020.05.033] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
32 [DOI: 10.1101/2020.06.08.20125112] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
33 Schub D, Klemis V, Schneitler S, Mihm J, Lepper PM, Wilkens H, Bals R, Eichler H, Gärtner BC, Becker SL, Sester U, Sester M, Schmidt T. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19. JCI Insight 2020;5:142167. [PMID: 32937615 DOI: 10.1172/jci.insight.142167] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 14.0] [Reference Citation Analysis]
34 Ravikumar N, Nallasamy K, Bansal A, Angurana SK, Basavaraja GV, Sundaram M, Lodha R, Gupta D, Jayashree M; Intensive Care Chapter of Indian Academy of Pediatrics. Novel Coronavirus 2019 (2019-nCoV) Infection: Part I - Preparedness and Management in the Pediatric Intensive Care Unit in Resource-limited Settings. Indian Pediatr 2020;57:324-34. [PMID: 32238612 [PMID: 32238612 DOI: 10.1007/s13312-020-1785-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
35 Tizaoui K, Zidi I, Lee KH, Ghayda RA, Hong SH, Li H, Smith L, Koyanagi A, Jacob L, Kronbichler A, Shin JI. Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19). Int J Biol Sci 2020;16:2906-23. [PMID: 33061805 DOI: 10.7150/ijbs.48812] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
36 Ortiz-Prado E, Simbaña-Rivera K, Gómez-Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, Muslin C, Jaramillo AMG, Barba-Ostria C, Cevallos-Robalino D, Sanches-SanMiguel H, Unigarro L, Zalakeviciute R, Gadian N, López-Cortés A. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis 2020;98:115094. [PMID: 32623267 DOI: 10.1016/j.diagmicrobio.2020.115094] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 49.5] [Reference Citation Analysis]
37 Shrestha R, Shrestha L. Coronavirus Disease 2019 (COVID-19): A Pediatric Perspective. JNMA J Nepal Med Assoc 2020;58:525-32. [PMID: 32827020 DOI: 10.31729/jnma.4977] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
38 Ashary N, Bhide A, Chakraborty P, Colaco S, Mishra A, Chhabria K, Jolly MK, Modi D. Single-Cell RNA-seq Identifies Cell Subsets in Human Placenta That Highly Expresses Factors Driving Pathogenesis of SARS-CoV-2. Front Cell Dev Biol 2020;8:783. [PMID: 32974340 DOI: 10.3389/fcell.2020.00783] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
39 Hasan A, Al-Ozairi E, Al-Baqsumi Z, Ahmad R, Al-Mulla F. Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches. Immunotargets Ther 2021;10:63-85. [PMID: 33728277 DOI: 10.2147/ITT.S280706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
40 Atif M, Malik I. Why is Pakistan vulnerable to COVID-19 associated morbidity and mortality? A scoping review. Int J Health Plann Manage 2020;35:1041-54. [PMID: 32700410 DOI: 10.1002/hpm.3016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
41 Al-Qahtani AA. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Emergence, history, basic and clinical aspects. Saudi J Biol Sci 2020;27:2531-8. [PMID: 32336927 DOI: 10.1016/j.sjbs.2020.04.033] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 17.0] [Reference Citation Analysis]
42 Huang F, Li Y, Leung EL, Liu X, Liu K, Wang Q, Lan Y, Li X, Yu H, Cui L, Luo H, Luo L. A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19). Pharmacol Res 2020;158:104929. [PMID: 32442720 DOI: 10.1016/j.phrs.2020.104929] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 16.5] [Reference Citation Analysis]
43 Gao H, Zhang Y, Jiang H, Hu X, Zhang Y, Zhou X, Zhong F, Lin C, Li J, Luo J, Zhang J. Crystal structures of human coronavirus NL63 main protease at different pH values. Acta Crystallogr F Struct Biol Commun 2021;77:348-55. [PMID: 34605439 DOI: 10.1107/S2053230X21009523] [Reference Citation Analysis]
44 Yarmohammadi A, Yarmohammadi M, Fakhri S, Khan H. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review. Eur J Pharmacol 2021;890:173620. [PMID: 33038418 DOI: 10.1016/j.ejphar.2020.173620] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
45 Shaban MS, Müller C, Mayr-Buro C, Weiser H, Meier-Soelch J, Albert BV, Weber A, Linne U, Hain T, Babayev I, Karl N, Hofmann N, Becker S, Herold S, Schmitz ML, Ziebuhr J, Kracht M. Multi-level inhibition of coronavirus replication by chemical ER stress. Nat Commun 2021;12:5536. [PMID: 34545074 DOI: 10.1038/s41467-021-25551-1] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
46 Friedman N, Jacob-Hirsch J, Drori Y, Eran E, Kol N, Nayshool O, Mendelson E, Rechavi G, Mandelboim M. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells. PLoS One 2021;16:e0247128. [PMID: 33630927 DOI: 10.1371/journal.pone.0247128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
47 Chakravarty D, Das Sarma J. Murine-β-coronavirus-induced neuropathogenesis sheds light on CNS pathobiology of SARS-CoV2. J Neurovirol 2021;27:197-216. [PMID: 33547593 DOI: 10.1007/s13365-021-00945-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Belizário JE. Immunity, virus evolution, and effectiveness of SARS-CoV-2 vaccines. Braz J Med Biol Res 2021;54:e10725. [PMID: 33729394 DOI: 10.1590/1414-431X202010725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Teimouri H, Maali A; Department of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran, Pasteur Institute of Iran. Single-Nucleotide Polymorphisms in Host Pattern-Recognition Receptors Show Association with Antiviral Responses against SARS-CoV-2, in-silico Trial. JoMMID 2020;8:65-70. [DOI: 10.29252/jommid.8.2.65] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 de Wilde AH, Zevenhoven-Dobbe JC, Beugeling C, Chatterji U, de Jong D, Gallay P, Szuhai K, Posthuma CC, Snijder EJ. Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell culture. Virology 2018;517:148-56. [PMID: 29249267 DOI: 10.1016/j.virol.2017.11.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
51 Silva SJRD, Germano Mendes RP, Alves da Silva CT, Lorusso A, Kohl A, Pena L. Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems. J Gen Virol 2020;101:1021-4. [PMID: 32579100 DOI: 10.1099/jgv.0.001458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Altaf A, Iqbal W, Younis S, Deebah F. Current Scenario of Covid-19 with Epidemiological and Phylogenetic Analysis of Pakistani Coronavirus: A Review. J Bioresource Manage 2020;7:45-65. [DOI: 10.35691/jbm.0202.0139] [Reference Citation Analysis]
53 Sturley SL, Rajakumar T, Hammond N, Higaki K, Márka Z, Márka S, Munkacsi AB. Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity. J Lipid Res 2020;61:972-82. [PMID: 32457038 DOI: 10.1194/jlr.R120000851] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
54 Palacios Cruz M, Santos E, Velázquez Cervantes MA, León Juárez M. COVID-19, a worldwide public health emergency. Rev Clin Esp 2020:S0014-2565(20)30092-8. [PMID: 32204922 DOI: 10.1016/j.rce.2020.03.001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 22.5] [Reference Citation Analysis]
55 Varahachalam SP, Lahooti B, Chamaneh M, Bagchi S, Chhibber T, Morris K, Bolanos JF, Kim NY, Kaushik A. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects. Int J Nanomedicine 2021;16:539-60. [PMID: 33519200 DOI: 10.2147/IJN.S283686] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 13.0] [Reference Citation Analysis]
56 Ena J, Wenzel RP. A Novel Coronavirus Emerges. Rev Clin Esp (Barc) 2020;220:115-6. [PMID: 32063263 DOI: 10.1016/j.rce.2020.01.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
57 Singh N, Rai SN, Singh V, Singh MP. Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19. J Chem Neuroanat 2020;110:101874. [PMID: 33091590 DOI: 10.1016/j.jchemneu.2020.101874] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
58 Kim JM, Kim HM, Lee EJ, Jo HJ, Yoon Y, Lee NJ, Son J, Lee YJ, Kim MS, Lee YP, Chae SJ, Park KR, Cho SR, Park S, Kim SJ, Wang E, Woo S, Lim A, Park SJ, Jang J, Chung YS, Chin BS, Lee JS, Lim D, Han MG, Yoo CK. Detection and Isolation of SARS-CoV-2 in Serum, Urine, and Stool Specimens of COVID-19 Patients from the Republic of Korea. Osong Public Health Res Perspect 2020;11:112-7. [PMID: 32528816 DOI: 10.24171/j.phrp.2020.11.3.02] [Cited by in Crossref: 69] [Cited by in F6Publishing: 52] [Article Influence: 34.5] [Reference Citation Analysis]
59 de Wilde AH, Pham U, Posthuma CC, Snijder EJ. Cyclophilins and cyclophilin inhibitors in nidovirus replication. Virology 2018;522:46-55. [PMID: 30014857 DOI: 10.1016/j.virol.2018.06.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
60 Manhas S, Anjali A, Mansoor S, Sharma V, Ahmad A, Rehman MU, Ahmad P. Covid-19 Pandemic and Current Medical Interventions. Arch Med Res 2020;51:473-81. [PMID: 32499154 DOI: 10.1016/j.arcmed.2020.05.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
61 Song P, Li W, Xie J, Hou Y, You C. Cytokine storm induced by SARS-CoV-2. Clin Chim Acta 2020;509:280-7. [PMID: 32531256 DOI: 10.1016/j.cca.2020.06.017] [Cited by in Crossref: 174] [Cited by in F6Publishing: 155] [Article Influence: 87.0] [Reference Citation Analysis]
62 Santos JD, Vitorino I, Reyes F, Vicente F, Lage OM. From Ocean to Medicine: Pharmaceutical Applications of Metabolites from Marine Bacteria. Antibiotics (Basel) 2020;9:E455. [PMID: 32731464 DOI: 10.3390/antibiotics9080455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
63 Tahir Ul Qamar M, Shahid F, Aslam S, Ashfaq UA, Aslam S, Fatima I, Fareed MM, Zohaib A, Chen LL. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2. Infect Dis Poverty 2020;9:132. [PMID: 32938504 DOI: 10.1186/s40249-020-00752-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
64 Zhou Z, Sun Y, Yan X, Tang X, Li Q, Tan Y, Lan T, Ma J. Swine acute diarrhea syndrome coronavirus (SADS-CoV) antagonizes interferon-β production via blocking IPS-1 and RIG-I. Virus Res 2020;278:197843. [PMID: 31884203 DOI: 10.1016/j.virusres.2019.197843] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
65 Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov. 2020;6:14. [PMID: 32194980 DOI: 10.1038/s41421-020-0153-3] [Cited by in Crossref: 655] [Cited by in F6Publishing: 618] [Article Influence: 327.5] [Reference Citation Analysis]
66 Prezioso C, Marcocci ME, Palamara AT, De Chiara G, Pietropaolo V. The "Three Italy" of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia. J Neurovirol 2020;26:311-23. [PMID: 32548750 DOI: 10.1007/s13365-020-00862-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
67 Mishra P, Sohrab S, Mishra SK. A review on the phytochemical and pharmacological properties of Hyptis suaveolens (L.) Poit. Futur J Pharm Sci 2021;7:65. [PMID: 33728353 DOI: 10.1186/s43094-021-00219-1] [Reference Citation Analysis]
68 Ngai HW, Kim DH, Hammad M, Gutova M, Aboody K, Cox CD. Stem Cell‐based therapies for COVID‐19‐related acute respiratory distress syndrome. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.17265] [Reference Citation Analysis]
69 Alshammary AF, Al-Sulaiman AM. The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences. Virulence 2021;12:1771-94. [PMID: 34251989 DOI: 10.1080/21505594.2021.1929800] [Reference Citation Analysis]
70 Al-Otaibi ST. The battle against Coronavirus disease 2019 (COVID-19) in the Kingdom of Saudi Arabia. Public health perspective. Saudi Med J 2020;41:1285-91. [PMID: 33294885 DOI: 10.15537/smj.2020.12.25459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Laise P, Bosker G, Sun X, Shen Y, Douglass EF, Karan C, Realubit RB, Pampou S, Califano A, Alvarez MJ. The Host Cell ViroCheckpoint: Identification and Pharmacologic Targeting of Novel Mechanistic Determinants of Coronavirus-Mediated Hijacked Cell States. bioRxiv 2020:2020. [PMID: 32511361 DOI: 10.1101/2020.05.12.091256] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
72 Li X, Peng T. Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery. Front Pharmacol 2021;12:660710. [PMID: 34017257 DOI: 10.3389/fphar.2021.660710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
73 Pooladanda V, Thatikonda S, Godugu C. The current understanding and potential therapeutic options to combat COVID-19. Life Sci 2020;254:117765. [PMID: 32437797 DOI: 10.1016/j.lfs.2020.117765] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 19.0] [Reference Citation Analysis]
74 Sun L, Zhao C, Fu Z, Fu Y, Su Z, Li Y, Zhou Y, Tan Y, Li J, Xiang Y, Nie X, Zhang J, Liu F, Zhao S, Xie S, Peng G. Genome-scale CRISPR screen identifies TMEM41B as a multi-function host factor required for coronavirus replication. PLoS Pathog 2021;17:e1010113. [PMID: 34871328 DOI: 10.1371/journal.ppat.1010113] [Reference Citation Analysis]
75 Sakr R, Ghsoub C, Rbeiz C, Lattouf V, Riachy R, Haddad C, Zoghbi M. COVID-19 detection by dogs: from physiology to field application-a review article. Postgrad Med J 2021:postgradmedj-2020-139410. [PMID: 33574179 DOI: 10.1136/postgradmedj-2020-139410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 French Society of Stomatology, Maxillo-Facial Surgery and Oral Surgery (SFSCMFCO). Practitioners specialized in oral health and coronavirus disease 2019: Professional guidelines from the French society of stomatology, maxillofacial surgery and oral surgery, to form a common front against the infectious risk. J Stomatol Oral Maxillofac Surg 2020;121:155-8. [PMID: 32307085 DOI: 10.1016/j.jormas.2020.03.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
77 Farhat Ullah M, Ali Y, Ramzan Khan M, Ullah Khan I, Yan B, Ijaz Khan M, Malik MY. A review of COVID-19: Treatment Strategies and CRISPR/Cas9 gene editing technology approaches to the coronavirus disease. Saudi J Biol Sci 2021. [PMID: 34658640 DOI: 10.1016/j.sjbs.2021.10.020] [Reference Citation Analysis]
78 Khan RJ, Jha RK, Amera GM, Jain M, Singh E, Pathak A, Singh RP, Muthukumaran J, Singh AK. Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase. J Biomol Struct Dyn 2021;39:2679-92. [PMID: 32266873 DOI: 10.1080/07391102.2020.1753577] [Cited by in Crossref: 70] [Cited by in F6Publishing: 84] [Article Influence: 35.0] [Reference Citation Analysis]
79 Liu CH, Lu CH, Wong SH, Lin LT. Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects. Front Immunol 2020;11:616595. [PMID: 33613542 DOI: 10.3389/fimmu.2020.616595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
80 Habibzadeh P, Stoneman EK. The Novel Coronavirus: A Bird's Eye View. Int J Occup Environ Med. 2020;11:65-71. [PMID: 32020915 DOI: 10.15171/ijoem.2020.1921] [Cited by in Crossref: 137] [Cited by in F6Publishing: 113] [Article Influence: 68.5] [Reference Citation Analysis]
81 Ujjan ID, Devrajani BR, Ghanghro AA, Shah SZA. The clinical and demographical profile of Coronavirus illness: The tale of Tablighi Jamaat and Zaireen in Quarantine / Isolation center at Sukkur and Hyderabad. Pak J Med Sci 2020;36:S12-6. [PMID: 32582307 DOI: 10.12669/pjms.36.COVID19-S4.2829] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
82 Labeau A, Fery-Simonian L, Lefevre-Utile A, Pourcelot M, Bonnet-Madin L, Soumelis V, Lotteau V, Vidalain PO, Amara A, Meertens L. Characterization and functional interrogation of the SARS-CoV-2 RNA interactome. Cell Rep 2022;39:110744. [PMID: 35477000 DOI: 10.1016/j.celrep.2022.110744] [Reference Citation Analysis]
83 Min YQ, Mo Q, Wang J, Deng F, Wang H, Ning YJ. SARS-CoV-2 nsp1: Bioinformatics, Potential Structural and Functional Features, and Implications for Drug/Vaccine Designs. Front Microbiol 2020;11:587317. [PMID: 33133055 DOI: 10.3389/fmicb.2020.587317] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
84 Prashantha CN, Gouthami K, Lavanya L, Bhavanam S, Jakhar A, Shakthiraju RG, Suraj V, Sahana KV, Sujana HS, Guruprasad NM, Ramachandra R. Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus. J Mol Graph Model 2021;102:107769. [PMID: 33152616 DOI: 10.1016/j.jmgm.2020.107769] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
85 Salman M, Mustafa ZU, Asif N, Zaidi HA, Hussain K, Shehzadi N, Khan TM, Saleem Z. Knowledge, attitude and preventive practices related to COVID-19: a cross-sectional study in two Pakistani university populations. Drugs Ther Perspect 2020;:1-7. [PMID: 32395069 DOI: 10.1007/s40267-020-00737-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
86 Mann R, Perisetti A, Gajendran M, Gandhi Z, Umapathy C, Goyal H. Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks. Front Med (Lausanne). 2020;7:581521. [PMID: 33282890 DOI: 10.3389/fmed.2020.581521] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
87 Somasundaram NP, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Dissanayake HA, Yogendranathan N, Gamage KKK, de Silva NL, Sumanatilleke M, Katulanda P, Grossman AB. The Impact of SARS-Cov-2 Virus Infection on the Endocrine System. J Endocr Soc. 2020;4:bvaa082. [PMID: 32728654 DOI: 10.1210/jendso/bvaa082] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
88 Chela HK, Pasha SB, Basar O, Daglilar E, Tahan V. Liver in the limelight in the corona (COVID-19) time. World J Clin Cases 2020; 8(16): 3405-3410 [PMID: 32913847 DOI: 10.12998/wjcc.v8.i16.3405] [Reference Citation Analysis]
89 Zhai T, Zhang F, Haider S, Kraut D, Huang Z. An Integrated Computational and Experimental Approach to Identifying Inhibitors for SARS-CoV-2 3CL Protease. Front Mol Biosci 2021;8:661424. [PMID: 34079818 DOI: 10.3389/fmolb.2021.661424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Liu S, Zhi Y, Ying S. COVID-19 and Asthma: Reflection During the Pandemic. Clinic Rev Allerg Immunol 2020;59:78-88. [DOI: 10.1007/s12016-020-08797-3] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 29.5] [Reference Citation Analysis]
91 Kurtaiş Aytür Y, Köseoğlu BF, Özyemişçi Taşkıran Ö, Ordu-Gökkaya NK, Ünsal Delialioğlu S, Sonel Tur B, Sarıkaya S, Şirzai H, Tekdemir Tiftik T, Alemdaroğlu E, Ayhan FF, Duyur Çakıt BD, Genç A, Gündoğdu İ, Güzel R, Demirbağ Karayel D, Bilir Kaya B, Öken Ö, Özdemir H, Soyupek F, Tıkız C. Pulmonary rehabilitation principles in SARS-COV-2 infection (COVID-19): A guideline for the acute and subacute rehabilitation. Turk J Phys Med Rehabil 2020;66:104-20. [PMID: 32760887 DOI: 10.5606/tftrd.2020.6444] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
92 Kanakan A, Mishra N, Srinivasa Vasudevan J, Sahni S, Khan A, Sharma S, Pandey R. Threading the Pieces Together: Integrative Perspective on SARS-CoV-2. Pathogens 2020;9:E912. [PMID: 33158051 DOI: 10.3390/pathogens9110912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Muñoz-Basagoiti J, Perez-Zsolt D, Carrillo J, Blanco J, Clotet B, Izquierdo-Useros N. SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus. Membranes (Basel) 2021;11:64. [PMID: 33477477 DOI: 10.3390/membranes11010064] [Reference Citation Analysis]
94 Waqas M, Haider A, Sufyan M, Siraj S, Sehgal SA. Determine the Potential Epitope Based Peptide Vaccine Against Novel SARS-CoV-2 Targeting Structural Proteins Using Immunoinformatics Approaches. Front Mol Biosci 2020;7:227. [PMID: 33195402 DOI: 10.3389/fmolb.2020.00227] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
95 Oberemok VV, Laikova KV, Yurchenko KA, Fomochkina II, Kubyshkin AV. SARS-CoV-2 will continue to circulate in the human population: an opinion from the point of view of the virus-host relationship. Inflamm Res 2020;69:635-40. [PMID: 32350571 DOI: 10.1007/s00011-020-01352-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
96 Chen W, Xiao Q, Fang Z, Lv X, Yao M, Deng M. Correlation Analysis between the Viral Load and the Progression of COVID-19. Comput Math Methods Med 2021;2021:9926249. [PMID: 34122620 DOI: 10.1155/2021/9926249] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Souza E Souza KFC, Moraes BPT, Paixão ICNP, Burth P, Silva AR, Gonçalves-de-Albuquerque CF. Na+/K+-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection. Front Pharmacol 2021;12:624704. [PMID: 33935717 DOI: 10.3389/fphar.2021.624704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections? Front Physiol 2020;11:571416. [PMID: 33510644 DOI: 10.3389/fphys.2020.571416] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 40.0] [Reference Citation Analysis]
99 Wang Y, Pang SC, Yang Y. A potential association between immunosenescence and high COVID-19 related mortality among elderly patients with cardiovascular diseases. Immun Ageing 2021;18:25. [PMID: 34074305 DOI: 10.1186/s12979-021-00234-z] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
100 Koma T, Adachi S, Doi N, Adachi A, Nomaguchi M. Toward Understanding Molecular Bases for Biological Diversification of Human Coronaviruses: Present Status and Future Perspectives. Front Microbiol 2020;11:2016. [PMID: 32983025 DOI: 10.3389/fmicb.2020.02016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
101 Dhamad AE, Abdal Rhida MA. COVID-19: molecular and serological detection methods. PeerJ 2020;8:e10180. [PMID: 33083156 DOI: 10.7717/peerj.10180] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
102 Wang Y, Wang L, Li X, Gong Z. Clinical Challenges in an Outbreak of COVID-19 in Wuhan, China: Concerns from Frontiers. Curr Infect Dis Rep 2020;22:30. [PMID: 32982600 DOI: 10.1007/s11908-020-00738-7] [Reference Citation Analysis]
103 Jelinek HF, Mousa M, Alefishat E, Osman W, Spence I, Bu D, Feng SF, Byrd J, Magni PA, Sahibzada S, Tay GK, Alsafar HS. Evolution, Ecology, and Zoonotic Transmission of Betacoronaviruses: A Review. Front Vet Sci 2021;8:644414. [PMID: 34095271 DOI: 10.3389/fvets.2021.644414] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
104 Loganathan T, Ramachandran S, Shankaran P, Nagarajan D, Mohan S S. Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach. PeerJ 2020;8:e9357. [PMID: 32566414 DOI: 10.7717/peerj.9357] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
105 Rhazouani A, Aziz K, Gamrani H, Gebrati L, Uddin MS, Faissal A. Can the application of graphene oxide contribute to the fight against COVID-19? Antiviral activity, diagnosis and prevention. Curr Res Pharmacol Drug Discov 2021;2:100062. [PMID: 34870157 DOI: 10.1016/j.crphar.2021.100062] [Reference Citation Analysis]
106 Wu T, Zuo Z, Kang S, Jiang L, Luo X, Xia Z, Liu J, Xiao X, Ye M, Deng M. Multi-organ Dysfunction in Patients with COVID-19: A Systematic Review and Meta-analysis. Aging Dis 2020;11:874-94. [PMID: 32765952 DOI: 10.14336/AD.2020.0520] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
107 Hazafa A, Ur-Rahman K, Haq IU, Jahan N, Mumtaz M, Farman M, Naeem H, Abbas F, Naeem M, Sadiqa S, Bano S. The broad-spectrum antiviral recommendations for drug discovery against COVID-19. Drug Metab Rev 2020;52:408-24. [PMID: 32546018 DOI: 10.1080/03602532.2020.1770782] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
108 Kalejaiye TD, Bhattacharya R, Burt MA, Travieso T, Okafor AE, Mou X, Blasi M, Musah S. SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes. Front Cell Dev Biol 2022;10:855340. [DOI: 10.3389/fcell.2022.855340] [Reference Citation Analysis]
109 El Kantar S, Nehmeh B, Saad P, Mitri G, Estephan C, Mroueh M, Akoury E, Taleb RI. Derivatization and combination therapy of current COVID-19 therapeutic agents: a review of mechanistic pathways, adverse effects, and binding sites. Drug Discov Today 2020:S1359-6446(20)30307-X. [PMID: 32801052 DOI: 10.1016/j.drudis.2020.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
110 Lee AR, Park YK, Dezhbord M, Kim K. Interaction between the Hepatitis B Virus and Cellular FLIP Variants in Viral Replication and the Innate Immune System. Viruses 2022;14:373. [DOI: 10.3390/v14020373] [Reference Citation Analysis]
111 Singh E, Khan RJ, Jha RK, Amera GM, Jain M, Singh RP, Muthukumaran J, Singh AK. A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods. J Genet Eng Biotechnol 2020;18:69. [PMID: 33141358 DOI: 10.1186/s43141-020-00085-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
112 Favas TT, Dev P, Chaurasia RN, Chakravarty K, Mishra R, Joshi D, Mishra VN, Kumar A, Singh VK, Pandey M, Pathak A. Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions. Neurol Sci 2020;41:3437-70. [PMID: 33089477 DOI: 10.1007/s10072-020-04801-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 19.0] [Reference Citation Analysis]
113 Sirpilla O, Bauss J, Gupta R, Underwood A, Qutob D, Freeland T, Bupp C, Carcillo J, Hartog N, Rajasekaran S, Prokop JW. SARS-CoV-2-Encoded Proteome and Human Genetics: From Interaction-Based to Ribosomal Biology Impact on Disease and Risk Processes. J Proteome Res 2020;19:4275-90. [PMID: 32686937 DOI: 10.1021/acs.jproteome.0c00421] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
114 Akbarzadeh-Khiavi M, Torabi M, Rahbarnia L, Safary A. Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection. Infection 2021. [PMID: 34902115 DOI: 10.1007/s15010-021-01730-6] [Reference Citation Analysis]
115 Wu CY, Yu XP, Ma AHY, Wang LP, Yang NB, Li GX, Shi JJ, Qian GQ. Coronavirus disease 19 with gastrointestinal symptoms as initial manifestations: a case report. J Int Med Res 2020;48:300060520952256. [PMID: 32910698 DOI: 10.1177/0300060520952256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
116 Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res 2020;7:11. [PMID: 32169119 DOI: 10.1186/s40779-020-00240-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Miyazawa M. Immunopathogenesis of SARS-CoV-2-induced pneumonia: lessons from influenza virus infection. Inflamm Regen 2020;40:39. [PMID: 33062077 DOI: 10.1186/s41232-020-00148-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
118 Perez A, Kogan-Liberman D, Sheflin-Findling S, Raizner A, Ahuja KL, Ovchinsky N. Presentation of Severe Acute Respiratory Syndrome-Coronavirus 2 Infection as Cholestatic Jaundice in Two Healthy Adolescents. J Pediatr 2020:S0022-3476(20)30953-7. [PMID: 32710910 DOI: 10.1016/j.jpeds.2020.07.054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
119 Liu J, Tao D, Chen X, Shen L, Zhu L, Xu B, Liu H, Zhao S, Li X, Liu X, Xie S, Niu L. Detection of Four Porcine Enteric Coronaviruses Using CRISPR-Cas12a Combined with Multiplex Reverse Transcriptase Loop-Mediated Isothermal Amplification Assay. Viruses 2022;14:833. [PMID: 35458562 DOI: 10.3390/v14040833] [Reference Citation Analysis]
120 Nikonova AA, Faizuloev EB, Gracheva AV, Isakov IY, Zverev VV. Genetic Diversity and Evolution of the Biological Features of the Pandemic SARS-CoV-2. Acta Naturae 2021;13:77-88. [PMID: 34707899 DOI: 10.32607/actanaturae.11337] [Reference Citation Analysis]
121 Chavda V, Chaurasia B, Fiorindi A, Umana GE, Lu B, Montemurro N. Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities. Neurology International 2022;14:391-405. [DOI: 10.3390/neurolint14020032] [Reference Citation Analysis]
122 Société Française de Stomatologie, Chirurgie Maxillo-Faciale et Chirurgie Orale (SFSCMFCO). [Practitioners specialized in oral health and coronavirus disease 2019: Professional guidelines from the French society of stomatology, maxillofacial surgery and oral surgery, to form a common front against the infectious risk]. J Stomatol Oral Maxillofac Surg 2020;121:e3-6. [PMID: 32307086 DOI: 10.1016/j.jormas.2020.03.012] [Reference Citation Analysis]
123 Ahmed M. Coronavirus Disease 2019: A Gastroenterologist's Perspective in May 2020. Gastroenterology Res 2020;13:89-95. [PMID: 32655724 DOI: 10.14740/gr1292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
124 Ovsyannikova IG, Haralambieva IH, Crooke SN, Poland GA, Kennedy RB. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Immunol Rev 2020;296:205-19. [PMID: 32658335 DOI: 10.1111/imr.12897] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 28.5] [Reference Citation Analysis]
125 Siddiqui AA, Alshammary F, Amin J, Rathore HA, Hassan I, Ilyas M, Alam MK. Knowledge and practice regarding prevention of COVID-19 among the Saudi Arabian population. Work 2020;66:767-75. [PMID: 32925138 DOI: 10.3233/WOR-203223] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
126 Kamle S, Ma B, He CH, Akosman B, Zhou Y, Lee CM, El-Deiry WS, Huntington K, Liang O, Machan JT, Kang MJ, Shin HJ, Mizoguchi E, Lee CG, Elias JA. Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19. JCI Insight 2021;6:e148749. [PMID: 34747367 DOI: 10.1172/jci.insight.148749] [Reference Citation Analysis]
127 Morris G, Athan E, Walder K, Bortolasci CC, O'Neil A, Marx W, Berk M, Carvalho AF, Maes M, Puri BK. Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19? Life Sci 2020;262:118541. [PMID: 33035581 DOI: 10.1016/j.lfs.2020.118541] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
128 Nascimento Junior JAC, Santos AM, Oliveira AMS, Guimarães AG, Quintans-Júnior LJ, Coutinho HDM, Martins N, Borges LP, Serafini MR. Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review. Front Public Health 2020;8:563095. [PMID: 33194964 DOI: 10.3389/fpubh.2020.563095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
129 Samanta J, Gupta R, Singh MP, Patnaik I, Kumar A, Kochhar R. Coronavirus disease 2019 and the pancreas. Pancreatology. 2020;20:1567-1575. [PMID: 33250089 DOI: 10.1016/j.pan.2020.10.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
130 Zahedipour F, Hosseini SA, Sathyapalan T, Majeed M, Jamialahmadi T, Al-Rasadi K, Banach M, Sahebkar A. Potential effects of curcumin in the treatment of COVID-19 infection. Phytother Res 2020;34:2911-20. [PMID: 32430996 DOI: 10.1002/ptr.6738] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 29.0] [Reference Citation Analysis]
131 Emile SH, Khan SM. Predictors of severe and critical COVID-19: A systematic review. World J Clin Infect Dis 2020; 10(2): 24-32 [DOI: 10.5495/wjcid.v10.i2.24] [Reference Citation Analysis]
132 Ahidjo BA, Loe MWC, Ng YL, Mok CK, Chu JJH. Current Perspective of Antiviral Strategies against COVID-19. ACS Infect Dis 2020;6:1624-34. [PMID: 32485102 DOI: 10.1021/acsinfecdis.0c00236] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
133 Mishra SK, Tripathi T. One year update on the COVID-19 pandemic: Where are we now? Acta Trop 2021;214:105778. [PMID: 33253656 DOI: 10.1016/j.actatropica.2020.105778] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
134 Anyfantakis D, Mantadaki AE, Mastronikolis S, Spandidos DA, Symvoulakis EK. COVID-19 pandemic and reasons to prioritize the needs of the health care system to ensure its sustainability: A scoping review from January to October 2020 (Review). Exp Ther Med 2021;22:1039. [PMID: 34373725 DOI: 10.3892/etm.2021.10471] [Reference Citation Analysis]
135 Li C, Su Q, Liu J, Chen L, Li Y, Tian X, Li W. Comparison of clinical and serological features of RT-PCR positive and negative COVID-19 patients. J Int Med Res 2021;49:300060520972658. [PMID: 33530774 DOI: 10.1177/0300060520972658] [Reference Citation Analysis]
136 Ciotti M, Maurici M, Santoro V, Coppola L, Sarmati L, De Carolis G, De Filippis P, Pica F. Viruses of Respiratory Tract: an Observational Retrospective Study on Hospitalized Patients in Rome, Italy. Microorganisms 2020;8:E501. [PMID: 32244685 DOI: 10.3390/microorganisms8040501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
137 Garg T, Desai A, Gala K, Warawdekar G, Tavri S. Interventional radiology preparedness during coronavirus disease (COVID-19) pandemic. Indian J Radiol Imaging 2021;31:S21-30. [PMID: 33814758 DOI: 10.4103/ijri.IJRI_442_20] [Reference Citation Analysis]
138 Alpdagtas S, Ilhan E, Uysal E, Sengor M, Ustundag CB, Gunduz O. Evaluation of current diagnostic methods for COVID-19. APL Bioeng 2020;4:041506. [PMID: 33305162 DOI: 10.1063/5.0021554] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
139 Abebe EC, Dejenie TA, Shiferaw MY, Malik T. The newly emerged COVID-19 disease: a systemic review. Virol J 2020;17:96. [PMID: 32641059 DOI: 10.1186/s12985-020-01363-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
140 Jang Y, Seo SH. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2. Arch Virol 2020;165:2205-11. [PMID: 32651741 DOI: 10.1007/s00705-020-04730-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
141 Sethumadhavan DV, Jabeena CA, Govindaraju G, Soman A, Rajavelu A. The severity of SARS-CoV-2 infection is dictated by host factors? Epigenetic perspectives. Curr Res Microb Sci 2021;2:100079. [PMID: 34725650 DOI: 10.1016/j.crmicr.2021.100079] [Reference Citation Analysis]
142 Salian VS, Wright JA, Vedell PT, Nair S, Li C, Kandimalla M, Tang X, Carmona Porquera EM, Kalari KR, Kandimalla KK. COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies. Mol Pharm 2021;18:754-71. [PMID: 33464914 DOI: 10.1021/acs.molpharmaceut.0c00608] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
143 Samaddar A, Grover M, Nag VL. Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena. Front Pharmacol. 2020;11:585888. [PMID: 33041830 DOI: 10.3389/fphar.2020.585888] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
144 Kumari A, Rajput VS, Nagpal P, Kukrety H, Grover S, Grover A. Dual inhibition of SARS-CoV-2 spike and main protease through a repurposed drug, rutin. J Biomol Struct Dyn 2020;:1-13. [PMID: 33357073 DOI: 10.1080/07391102.2020.1864476] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
145 Bandyopadhyay D, Akhtar T, Hajra A, Gupta M, Das A, Chakraborty S, Pal I, Patel N, Amgai B, Ghosh RK, Fonarow GC, Lavie CJ, Naidu SS. COVID-19 Pandemic: Cardiovascular Complications and Future Implications. Am J Cardiovasc Drugs. 2020;20:311-324. [PMID: 32578167 DOI: 10.1007/s40256-020-00420-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 20.0] [Reference Citation Analysis]
146 Sarkar R, Bhargava S, Mendiratta V. Virology and Etiopathogenesis of COVID-19 with Special Reference to Cutaneous Implications. Indian J Dermatol 2021;66:231-6. [PMID: 34446945 DOI: 10.4103/ijd.ijd_467_21] [Reference Citation Analysis]
147 Poulsen NN, von Brunn A, Hornum M, Blomberg Jensen M. Cyclosporine and COVID-19: Risk or favorable? Am J Transplant 2020;20:2975-82. [PMID: 32777170 DOI: 10.1111/ajt.16250] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
148 Olwenyi OA, Dyavar SR, Acharya A, Podany AT, Fletcher CV, Ng CL, Reid SP, Byrareddy SN. Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19). J Mol Med (Berl) 2020;98:1369-83. [PMID: 32808094 DOI: 10.1007/s00109-020-01961-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
149 Solanki V, Tiwari M, Tiwari V. Immunoinformatic approach to design a multiepitope vaccine targeting non-mutational hotspot regions of structural and non-structural proteins of the SARS CoV2. PeerJ 2021;9:e11126. [PMID: 33828922 DOI: 10.7717/peerj.11126] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Yi Y, Lagniton PNP, Ye S, Li E, Xu RH. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020;16:1753-1766. [PMID: 32226295 DOI: 10.7150/ijbs.45134] [Cited by in Crossref: 298] [Cited by in F6Publishing: 252] [Article Influence: 149.0] [Reference Citation Analysis]
151 Bawaskar HS, Bawaskar PH. From quarantine room: Physician perspective. J Family Med Prim Care 2020;9:5092-102. [PMID: 33409170 DOI: 10.4103/jfmpc.jfmpc_896_20] [Reference Citation Analysis]
152 Zhao Z, Lu K, Mao B, Liu S, Trilling M, Huang A, Lu M, Lin Y. The interplay between emerging human coronavirus infections and autophagy. Emerg Microbes Infect 2021;10:196-205. [PMID: 33399028 DOI: 10.1080/22221751.2021.1872353] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
153 Thiecke MJ, Yang EJ, Burren OS, Ray-Jones H, Spivakov M. Prioritisation of Candidate Genes Underpinning COVID-19 Host Genetic Traits Based on High-Resolution 3D Chromosomal Topology. Front Genet 2021;12:745672. [PMID: 34759959 DOI: 10.3389/fgene.2021.745672] [Reference Citation Analysis]
154 Lin X, Liang C, Zou L, Yin Y, Wang J, Chen D, Lan W. Advance of structural modification of nucleosides scaffold. Eur J Med Chem 2021;214:113233. [PMID: 33550179 DOI: 10.1016/j.ejmech.2021.113233] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
155 Thankam FG, Agrawal DK. Molecular chronicles of cytokine burst in patients with coronavirus disease 2019 (COVID-19) with cardiovascular diseases. J Thorac Cardiovasc Surg 2021;161:e217-26. [PMID: 32631657 DOI: 10.1016/j.jtcvs.2020.05.083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
156 Palacios Cruz M, Santos E, Velázquez Cervantes MA, León Juárez M. COVID-19, a worldwide public health emergency. Rev Clin Esp (Barc) 2021;221:55-61. [PMID: 33998479 DOI: 10.1016/j.rceng.2020.03.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
157 Nahalka J. Theoretical Analysis of S, M and N Structural Proteins by the Protein-RNA Recognition Code Leads to Genes/proteins that Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis. Front Genet 2021;12:763995. [PMID: 34659373 DOI: 10.3389/fgene.2021.763995] [Reference Citation Analysis]
158 Erener S. Diabetes, infection risk and COVID-19. Mol Metab. 2020;39:101044. [PMID: 32585364 DOI: 10.1016/j.molmet.2020.101044] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 30.0] [Reference Citation Analysis]
159 Konwar M, Sarma D. Advances in developing small molecule SARS 3CLpro inhibitors as potential remedy for corona virus infection. Tetrahedron 2021;77:131761. [PMID: 33230349 DOI: 10.1016/j.tet.2020.131761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
160 Park JY, Ryu J, Park JE, Hong EJ, Shin HJ. Heat shock protein 70 could enhance porcine epidemic diarrhoea virus replication by interacting with membrane proteins. Vet Res 2021;52:138. [PMID: 34717778 DOI: 10.1186/s13567-021-01006-9] [Reference Citation Analysis]
161 Palandri F, Breccia M, De Stefano V, Passamonti F. Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future Scenarios. Cancers (Basel) 2021;13:4750. [PMID: 34638236 DOI: 10.3390/cancers13194750] [Reference Citation Analysis]
162 Agranovsky AA. Structure and Expression of Large (+)RNA Genomes of Viruses of Higher Eukaryotes. Biochemistry (Mosc) 2021;86:248-61. [PMID: 33838627 DOI: 10.1134/S0006297921030020] [Reference Citation Analysis]
163 Mirzaei R, Karampoor S, Sholeh M, Moradi P, Ranjbar R, Ghasemi F. A contemporary review on pathogenesis and immunity of COVID-19 infection. Mol Biol Rep 2020;47:5365-76. [PMID: 32601923 DOI: 10.1007/s11033-020-05621-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
164 Tanner JE, Alfieri C. The Fatty Acid Lipid Metabolism Nexus in COVID-19. Viruses 2021;13:90. [PMID: 33440724 DOI: 10.3390/v13010090] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
165 Mohamed DZ, Ghoneim MES, Abu-Risha SES, Abdelsalam RA, Farag MA. Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management. World J Gastroenterol 2021; 27(28): 4504-4535 [PMID: 34366621 DOI: 10.3748/wjg.v27.i28.4504] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Emanoil AR, Stochino Loi E, Feki A, Ben Ali N. Focusing Treatment on Pregnant Women With COVID Disease. Front Glob Womens Health 2021;2:590945. [PMID: 34816175 DOI: 10.3389/fgwh.2021.590945] [Reference Citation Analysis]
167 de Vries AAF. SARS-CoV-2/COVID-19: a primer for cardiologists. Neth Heart J 2020;28:366-83. [PMID: 32671650 DOI: 10.1007/s12471-020-01475-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
168 Rahimi G, Rahimi B, Panahi M, Abkhiz S, Saraygord-Afshari N, Milani M, Alizadeh E. An overview of Betacoronaviruses-associated severe respiratory syndromes, focusing on sex-type-specific immune responses. Int Immunopharmacol 2021;92:107365. [PMID: 33440306 DOI: 10.1016/j.intimp.2021.107365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
169 Akter F, Araf Y, Naser IB, Promon SK. Prospect of 3D bioprinting over cardiac cell therapy and conventional tissue engineering in the treatment of COVID-19 patients with myocardial injury. Regen Ther 2021;18:447-56. [PMID: 34608441 DOI: 10.1016/j.reth.2021.09.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res 2020;7:11. [PMID: 32169119 DOI: 10.1186/s40779-020-00240-0] [Cited by in Crossref: 1097] [Cited by in F6Publishing: 1253] [Article Influence: 548.5] [Reference Citation Analysis]
171 Yi Y, Lagniton PNP, Ye S, Li E, Xu RH. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci 2020;16:1753-66. [PMID: 32226295 DOI: 10.7150/ijbs.45134] [Reference Citation Analysis]
172 Al Mahmasani L, Hodroj MH, Finianos A, Taher A. COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications. Ann Hematol 2021;100:1115-22. [PMID: 33527161 DOI: 10.1007/s00277-021-04441-y] [Reference Citation Analysis]
173 Adegboyega A, Boddie S, Dorvie H, Bolaji B, Adedoyin C, Moore SE. Social distance impact on church gatherings: Socio-behavioral implications. Journal of Human Behavior in the Social Environment 2021;31:221-34. [DOI: 10.1080/10911359.2020.1793869] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
174 Simoneau CR, Ott M. Modeling Multi-organ Infection by SARS-CoV-2 Using Stem Cell Technology. Cell Stem Cell 2020;27:859-68. [PMID: 33275899 DOI: 10.1016/j.stem.2020.11.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
175 Giannessi F, Aiello A, Franchi F, Percario ZA, Affabris E. The Role of Extracellular Vesicles as Allies of HIV, HCV and SARS Viruses. Viruses 2020;12:E571. [PMID: 32456011 DOI: 10.3390/v12050571] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
176 Li S, Yang J, Zhu Z, Zheng H. Porcine Epidemic Diarrhea Virus and the Host Innate Immune Response. Pathogens 2020;9:E367. [PMID: 32403318 DOI: 10.3390/pathogens9050367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]